190 related articles for article (PubMed ID: 28521880)
1. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
[TBL] [Abstract][Full Text] [Related]
2. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
3. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
[TBL] [Abstract][Full Text] [Related]
4. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
[TBL] [Abstract][Full Text] [Related]
5. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
6. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
7. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
[TBL] [Abstract][Full Text] [Related]
9. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Modeling of Hydrocortisone by Including Protein Binding to Corticosteroid-Binding Globulin.
Rozenveld E; Punt N; van Faassen M; van Beek AP; Touw DJ
Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745734
[TBL] [Abstract][Full Text] [Related]
13. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
[TBL] [Abstract][Full Text] [Related]
14. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children.
Michelet R; Melin J; Parra-Guillen ZP; Neumann U; Whitaker JM; Stachanow V; Huisinga W; Porter J; Blankenstein O; Ross RJ; Kloft C
Eur J Endocrinol; 2020 Oct; 183(4):357-368. PubMed ID: 32621587
[TBL] [Abstract][Full Text] [Related]
15. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.
Galbois A; Rudler M; Massard J; Fulla Y; Bennani A; Bonnefont-Rousselot D; Thibault V; Reignier S; Bourrier A; Poynard T; Thabut D
J Hepatol; 2010 Jun; 52(6):839-45. PubMed ID: 20385427
[TBL] [Abstract][Full Text] [Related]
16. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
[TBL] [Abstract][Full Text] [Related]
17. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
[TBL] [Abstract][Full Text] [Related]
18. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
[TBL] [Abstract][Full Text] [Related]
19. Residual endogenous corticosteroid production in patients with adrenal insufficiency.
Vulto A; Bergthorsdottir R; van Faassen M; Kema IP; Johannsson G; van Beek AP
Clin Endocrinol (Oxf); 2019 Sep; 91(3):383-390. PubMed ID: 31059146
[TBL] [Abstract][Full Text] [Related]
20. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]